Pathology Industry Market Research Reports, May 2013

Company Report: Sleep Apnea in Australia for Year 2013

• Company report
• May 2013
• 2 pages
• by Corporation

... For patients with mild to severe sleep disorders. Air liquide intends to pursue healthy sleep solutions Development by favouring the continuity of the company S management, led by marjan mikel and stephen ...

• Industries: Pathology
• Countries: Australia

Company Report: Pathology in France for Year 2013

• Company report
• May 2013
• 32 pages
• by Corporation

... That dicobalt edetate only be given when the patient is tending to lose or has lost consciousness. Distamine penicillamine a disease modifying antirheumatic drug (dmard) used for the treatment of rheumatoid ...

• Industries: Pathology
• Countries: France

Merck Research Laboratories - Company Report for Year 2013

• Company report
• April 2013
• 62 pages

... Such as cancer, cardiovascular and infectious diseases, thereby allowing early treatment. Predominantly, elisa-based tests are used to monitor various disease biomarkers. However, these tests can measure only ...

• Industries: Pathology
• Countries: United States

Company Report: Pathology for Year 2013

• Company report
• April 2013
• 12 pages

... attack or stroke. Atheronova is also conducting additional academic research, including a study of the effects of ahro 003 Supplementation on atherosclerotic ...

• Industries: Pathology

Company Report: Pathology in Canada for Year 2013

• Company report
• April 2013
• 2 pages

... breast cancer. It is reported that up to 30% of her2+ breast cancer patients develop brain metastasis for which therapeutic options are limited. Because of its ability to cross the blood-brain barrier ...

• Industries: Pathology
• Countries: Canada

VIVUS Inc. - Company Report for Year 2013

• Company report
• May 2013
• 2 pages
• by Corporation

• Industries: Pathology
• Countries: United States

Company Report: Pathology in The United States for Year 2013

• Company report
• April 2013
• 6 pages

• Industries: Pathology
• Countries: United States

Company Report: Pathology in The United States for Year 2013

• Company report
• May 2013
• 9 pages

• Industries: Pathology
• Countries: World, United States

Company Report: Pathology in The United States for Year 2013

• Company report
• May 2013
• 6 pages

• Industries: Pathology
• Countries: World, United States

Company Report: Pathology in The United States for Year 2013

• Company report
• May 2013
• 9 pages

... Stribild gilead hiv-1 infection aug. 27 Neutroval sicor biotech neutropenia aug. 29 Linzess forest ibs aug. 30 Xtandi astellas prostate cancer aug. 31 Bosulif pfizer leukemia sep. 4 Aubagio sanofi multiple ...

• Industries: Pathology
• Countries: World, United States

Company Report: Pathology in The United States and Ireland for Year 2013

• Company report
• May 2013
• 5 pages
• by Corporation

... Involved, even indirectly, with an important therapeutic area that addresses the needs of millions of patients who suffer from respiratory disease is particularly meaningful to all of us at elan." Relvar ...

• Industries: Pathology
• Countries: United States, Ireland

Pharmaceutical in Kenya : Innovation and Technology Trends

• Industry report
• April 2013
• 31 pages
• by Intergovernmental Agency

• Industries: Pathology
• Countries: Kenya

Cancer Sector (cancer, autoimmune disease, endocrine, nutritional and metabolic diseases) in The United Kingdom and The United States

• Industry report
• April 2013
• 49 pages

... Nonsurgical polyp removal complete colonic examination age 35 years or older; no history of colorectal cancer, inflammatory bowel disease, or large bowel resection; satisfactory completion of a food ...

• Industries: Pathology
• Countries: United Kingdom, United States

U.S. Pharmaceutical Business : Innovation and Technology Trends

• Industry report
• April 2013
• 23 pages

... To identify risk factors that contribute to someone developing a tmj disorder Oppera ii launched in 2012 to deepen understanding of risk factors and genetic markers for chronic pain conditions (maixner ...

• Industries: Pathology
• Countries: United States

The French Pharmaceutical Industry Brief

• Industry report
• April 2013
• 8 pages

... Of a pathologic oxygen supply dependency remains contro- versial. Study objective: to evaluate the relationship between oxygen delivery (do2) and oxygen consumption (vo2) during severe sepsis and to compare ...

• Industries: Pathology
• Countries: France

U.S. Pharmaceutical Industry

• Industry report
• May 2013
• 46 pages

... Sorbentstm competition 38 no approved therapies in the eu or us to prevent or treat organ failure Sepsis Ards and ali Burn injury Trauma Severe acute pancreatitis Cardiopulmonary bypass ...

• Industries: Pathology
• Countries: United States

Mental Illness Sector in The United States

• Industry report
• April 2013
• 22 pages

... Schizophrenia, bipolar disorder, schizoaffective disorder, major depressive disorder) Global assessment scale score > 50 Brief psychiatric rating scale score < 54 Competent to sign informed consent ...

• Industries: Pathology
• Countries: United States

Pharmaceutical in The United Kingdom : Innovation and Technology Trends

• Industry report
• April 2013
• 23 pages

... Official figures show. Circulatory conditions like heart disease remain the most common cause of death, contributing to a third of the deaths registered. But over the decade, mortality from ...

• Industries: Pathology
• Countries: United Kingdom

Pharmaceutical Market in The United States

• Industry report
• April 2013
• 34 pages

... Food environments, linking incentives to stores that commit to healthy food promotion. Strategy 2-5: examine the effects of u.S. Agriculture policies on diets and obesity. 21 Message environment ...

• Industries: Pathology
• Countries: United States

The Mexican Pharmaceutical Business : Key Market Figures

• Industry report
• April 2013
• 21 pages

... Diseases % of all deaths intestinal infectious diseases malignant neoplasms malnutrition and other anemias accidents chronic obstructive pulmonary disease diabetes mellitus liver diseases ...

• Industries: Pathology
• Countries: Mexico

The Malaysian Pharmaceutical Business Analysis

• Industry report
• April 2013
• 56 pages

... Or contraception for good family planning and avoidance of sti To strengthen antenatal care among teenagers in order to reduce complications eg anemia To encourage them to come for booking or check up ...

• Industries: Pathology
• Countries: Malaysia

U.S. Brain Tumor Industry (brain tumor, glioblastoma)

• Industry report
• May 2013
• 24 pages

... Uncertainty was positively correlated to five poms-sf subscales, anger, confusion, depression, fatigue, and tension (all with p ...

• Industries: Pathology
• Countries: United States

Pharmaceutical Sector in The United States

• Industry report
• May 2013
• 6 pages
• by Governmental Agency

... Such as heart attack, stroke, heart failure and end-stage kidney failure.13 cardiovascular diseases are costly to society; direct and indirect costs of cardiovascular diseases in the u.S. Are estimated ...

• Industries: Pathology
• Countries: United States

Pharmaceutical Business Analysis

• Industry report
• May 2013
• 53 pages

... Guidelines say People with diabetes and hypertension should be treated to a systolic blood pressure goal of 140 mmhg. Lower systolic targets (such as ...

• Industries: Pathology

Cardiovascular Disease Sector Trends (cardiovascular disease, blood disease, endocrine, nutritional and metabolic diseases) in India

• Industry report
• April 2013
• 22 pages
• by Non Governmental Organization (NGO)

• Industries: Pathology
• Countries: India, World

Pharmaceutical Key Market Figures

• Industry report
• April 2013
• 20 pages
• by Corporation

... Africa), latin america, canada, others *** >500% key products Mabthera/rituxan (+6%), for non-hodgkin S lymphoma (nhl), chronic lymphocytic leukemia (cll), rheumatoid arthritis, as well ...

• Industries: Pathology

Pharmaceutical Key Market Figures

• Industry report
• April 2013
• 19 pages
• by Corporation

• Industries: Pathology

Diabete Market Analysis (diabete, obesity, angina pectoris) in The United States

• Industry report
• April 2013
• 56 pages

• Industries: Pathology
• Countries: United States

The Swazi Pharmaceutical Industry

• Industry report
• May 2013
• 21 pages

... Production v livestock production v natural resources vdiscuss the roles of government on hiv/aids vdiscuss the roles of pepfar u.S government organization on hiv/aids vdiscuss the impact of hiv/aids ...

• Industries: Pathology
• Countries: Africa, World, Swaziland

Pharmaceutical Sector in The United States

• Industry report
• April 2013
• 43 pages

... In hemophilia a and b is recruiting patients 20/04/2013 aav-vector mediated gene transfer in hemophilia b Aav8 vector Packaged as complementary dimers within single virion Mediate transgene expression ...

• Industries: Pathology
• Countries: United States